entertainment -WSS

entertainment

author：leisure time 2025-09-30 18:54:25 - browse：41

Eli Lilly headquarters — Kristoffer Tripplaar/AP

SAN DIEGO – An experimental pill from Eli Lilly led to 14.7% weight loss on the highest dose in a 36-week trial, heating up the growing competition among drugmakers to develop an effective oral obesity therapy.

The mid-stage results for orforglipron match the estimates of 14-15% weight loss that Lilly gave in an investor call late last year. The full results, published Friday in the New England Journal of Medicine, were presented here to a packed conference room at the American Diabetes Association conference.

By the end of trial, the authors said, participants’ weight loss had not plateaued, suggesting potential for even greater weight loss over a longer treatment period.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Ambulance rides for just $100? Advisers want major billing fixes

leisure time

Wikipedia

WSS

STAT Executive Editor Rick Berke on STAT's 8th birthday

Abortion clinic in Cancun will cater to Americans

FDA approves Recor Medical high blood pressure device

More doctors should go into startup world

Close Medicare's dangerous gaps in addiction treatment coverage

A clever new way to fix Medicaid and graduate medical education

Wikipedia

entertainment

leisure time

United colonoscopy coverage change 'may cost lives,' doctors say

Abortion clinic in Cancun will cater to Americans

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

In Memoriam: Notable people who died in 2023

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

DIEP, the 'gold standard' of breast reconstruction, is under threat

Bird flu outbreak in cows is latest avian flu curveball

Medicare proposal to cover medical devices draws a mixed reaction

MultiPlan and major insurers sued for alleged medical price

explore

Cue Health's Covid

Orangutan used medicinal plant to treat wound, first time ever seen

Sanofi CEO defends move to abandon profit guidance, boost research

Why does health care cost so much? A reading guide

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

White House calls on federal agencies to crack down on AI abuses

Wikipedia

leisure time

Wikipedia

knowledge